Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-05-23 @ 8:02 AM
Study NCT ID:
NCT05864105
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-12
First Post:
2023-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma
Sponsor:
Biotheus Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PM8002 -B006C-HCC-R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None